Von Hippel-Lindau disease;De ziekte van Von Hippel-Lindau

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 11, 2000, Pages 497-501

  Los, M ^a,b   Links, T P ^a,c   Lenders, J W M ^a   Voest, E E ^a,b  

^a Sector Neuropsychologie V K   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN CANCER; CASE REPORT; CLEAR CELL CARCINOMA; CYSTADENOMA; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY CYST; MALE; METASTASIS; QUALITY OF LIFE; VISUAL IMPAIRMENT; VON HIPPEL LINDAU DISEASE;

ADULT; ANGIOMATOSIS; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EYE NEOPLASMS; FEMALE; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; RETINAL DISEASES;

EID: 0034635885     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Melmon KL, Rosen SW. Lindau's disease. Review of the literature and study of a large kindred. Am J Med 1964;36:595-617.
2. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
3. Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 1999;117:371-8.
4. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT. et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990;77:1151-63.
5. Wittebol-Post D, Hes FJ, Lips CJ. The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations. J Intern Med 1998;243:555-61.
6. Niemela M, Lim YJ, Soderman M, Jaaskelainen J, Lindquist C. Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg 1996;85:591-6.
7. Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 1996;149:2089-94.
8. Goldfarb DA. Nephron-sparing surgery and renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. J Intern Med 1998;243:563-7.
9. Maher ER, Kaelin jr WG. Von Hippel-Lindau disease. Medicine (Baltimore) 1997;76:381-91.
10. Libutti SK, Choyke PL, Bartlett DL, Vargas H, Walther M, Lubensky I, et al. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery 1998;124:1153-9.
11. Choyke PL, Glenn GM, Wagner JP, Lubensky IA, Thakore K, Zbar B. et al. Epididymal cystadenomas in von Hippel-Lindau disease. Urology 1997;49:926-31.
12. Manski TJ, Heffner DK, Glenn GM, Patronas NJ, Pikus AT, Katz D, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 1997;277:1461-6.
13. Hes FJ, Luijt RB van der. De ziekle van Von Hippel-Lindau: protocol voor diagnostiek en periodiek klinisch onderzoek. Ned Tijdschr Geneeskd 2000;144:505-9.
14. Los M, Zeamari S, Foekens JA, Gebbink MFBG, Voest EE. Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor gene. Cancer Res 1999;59: 4440-5.